不良事件报告

如果发生不良事件,患者应始终寻求医生或药剂师的建议。

如果您想向ELC Group s.r.o.报告不良事件,请在下面找到联系信息:

00420 224 910 672

(欧洲中部时间09.00-17.30)

00420 723 694 460

(24/7不间断)

有关其他任何问题,请与我们联系:

+420 22 491 0000或我们的 区域办事处。

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

00420 224 910 672

(09.00-17.30 CET)

00420 723 694 460

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

 

ELC集团

您的全球法规合作伙伴

ELC集团是一家成熟的全球性法规服务公司,与制药行业主要的利益相关方都拥有十年以上的合作经验。我们的服务涵盖了药品的全生命周期各阶段,包括从创新药物发现阶段到临床试验阶段,药物的注册申报,以及产品的成功上市营销。ELC集团始终将自己定位为帮助制药企业实现其维护大众健康目标的战略合作伙伴。

850+
clients
11,000
projects completed
60+
countries
“ELC总是会“付出额外的努力”去研究复杂的问题,并与药监局一起寻找处理各种不同问题的新方法。”

Sadiq Basha

法规事务主管, Strides Arcolab International Limited, 英国

‘We have partnered with ELC Group for a number of years now and have always found them extremely easy to work with. They are flexible and knowledgeable in their approach and projects are delivered on time and within budget.’

Andrew Macaulay

President-Europe, Famy Care, India

‘ELC Group proved to be a proactive partner and its expert team’s experience has proven to be useful, especially when it comes to regulatory intelligence and agency communication.’

Maria Niktari

Business Development Director, Pharmanel, Greece

‘The transition of PV activities, including the EU QPPV service from a UK-based PV service provider to ELC was very smooth and professional. We have received many positive comments internally, regarding the timelines and quality of the services. We consider the ELC Group as a competent and reliable pharmacovigilance partner for the PV services.’

Komal Patel

Medreich PLC, UK